2017 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Immunology, Natural killer T cell, CD1D, Cell biology and Antigen. As part of his studies on Immunology, Sebastian Joyce often connects relevant areas like Lineage. In his research, Cell culture, Synthetic antigen and Interleukin 15 is intimately related to Cell growth, which falls under the overarching field of Natural killer T cell.
He has included themes like Interleukin 12, Apolipoprotein E and Cytokine, Interleukin 4 in his CD1D study. His Cell biology study integrates concerns from other disciplines, such as Alpha, Cellular differentiation, T cell, Immune system and Negative selection. Sebastian Joyce works mostly in the field of Antigen, limiting it down to topics relating to Antigen presentation and, in certain cases, MHC class I.
His primary scientific interests are in Immunology, Antigen, Cell biology, Natural killer T cell and Immune system. His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Virology. His study looks at the intersection of Antigen and topics like Adjuvant with Ovalbumin, Dendritic cell, Immunization and Cancer immunotherapy.
His research integrates issues of Glycolipid, Transcription factor and INKT Cells in his study of Cell biology. His Natural killer T cell research is multidisciplinary, relying on both Receptor, Cell and Cytokine. His study focuses on the intersection of CD1D and fields such as CD1 with connections in the field of Lipid metabolism.
Immunology, Natural killer T cell, Antigen, Adjuvant and Cell biology are his primary areas of study. He is interested in Immune system, which is a field of Immunology. Cytotoxic T cell covers Sebastian Joyce research in Natural killer T cell.
The various areas that he examines in his Antigen study include Cancer immunotherapy and Virology. He has researched Adjuvant in several fields, including CD8 and Immunogenicity. His Cell biology research includes elements of Cell growth and T-cell receptor.
Sebastian Joyce mainly focuses on Antigen, Adjuvant, Immunogenicity, Virology and Cancer immunotherapy. In general Antigen study, his work on MHC class I and Immunodominance often relates to the realm of Imidazoquinoline, thereby connecting several areas of interest. His MHC class I research incorporates elements of Ecology, Cytokine, Natural killer T cell, CD1D and Chemokine.
His Adjuvant study necessitates a more in-depth grasp of Immunology. His Virology research includes themes of Epitope and Immunity. His study looks at the relationship between CD8 and fields such as T cell, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Mary K. Kennedy;Moira Glaccum;Sandra N. Brown;Eric A. Butz.
Journal of Experimental Medicine (2000)
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Sanjeev K Mendiratta;W.David Martin;Seokmann Hong;Alina Boesteanu.
Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol
Sebastian Joyce;Amina S. Woods;Jonathan W. Yewdell;Jack R. Bennink.
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis
Avneesh K. Singh;Michael T. Wilson;Seokmann Hong;Danyvid Olivares-Villagómez.
Journal of Experimental Medicine (2001)
Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways
Keunwook Lee;Prathyusha Gudapati;Srdjan Dragovic;Charles Spencer.
Glycolipid antigen induces long-term natural killer T cell anergy in mice
Vrajesh V. Parekh;Michael T. Wilson;Danyvid Olivares-Villagómez;Avneesh K. Singh.
Journal of Clinical Investigation (2005)
The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.
Michael T. Wilson;Cecilia Johansson;Danyvid Olivares-Villagómez;Avneesh K. Singh.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor
Li Yang;Noboru Yamagata;Rajwardhan Yadav;Suzanne Brandon.
Journal of Clinical Investigation (2003)
CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection
Alison Motsinger;David W. Haas;Aleksandar K. Stanic;Luc Van Kaer.
Journal of Experimental Medicine (2002)
Natural killer T cells accelerate atherogenesis in mice.
Yukihito Nakai;Kazuya Iwabuchi;Satoshi Fujii;Naoki Ishimori.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: